| Dr Robert Anton Gessler, MD | |
|
10710 Charter Dr, Suite 130, Columbia, MD 21044-3128 | |
| (410) 772-7000 | |
| (410) 772-7072 |
| Full Name | Dr Robert Anton Gessler |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 10710 Charter Dr, Columbia, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427122498 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | D0036854 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Anton Gessler, MD 10710 Charter Dr, Suite 130, Columbia, MD 21044-3128 Ph: (410) 772-7000 | Dr Robert Anton Gessler, MD 10710 Charter Dr, Suite 130, Columbia, MD 21044-3128 Ph: (410) 772-7000 |
News Archive
Physical therapists are calling for definitive vestibular screenings and assessment measures for US military service members with blast-induced traumatic brain injuries (BITBI). According to a Scholarly Opinion Piece in the September issue of Physical Therapy, the scientific journal of the American Physical Therapy Association (APTA), vestibular rehabilitation must be included as part of successful treatment for those who have been injured by blasts and experience vestibular symptoms such as vertigo, gaze instability, and motion intolerance.
Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox, an investigational treatment for adult patients diagnosed with schizophrenia, at the 2007 annual meeting of the American Psychiatric Association.
A recent study published in Rheumatology finds that osteitis/bone marrow edema as measured by magnetic resonance imaging was present in healthy people. However, it did not significantly increase due to intense physical activity.
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD. Parkinson's disease is a chronic, slowly progressive and potentially debilitating neurological condition affecting nearly one million people in the U.S., with one person newly diagnosed every nine minutes.
› Verified 9 days ago
Dr. Alejandro Rodriguez, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite 130, Columbia, MD 21044 Phone: 410-772-7000 Fax: 410-772-7072 | |
Jennifer L Bepple, MD Urology Medicare: Medicare Enrolled Practice Location: 10710 Charter Dr., Suite 130, Columbia, MD 21044 Phone: 410-772-7000 Fax: 410-772-7089 | |
Dr. John Joseph Kishel, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite 130, Columbia, MD 21044 Phone: 410-772-7000 Fax: 410-772-7072 | |
Dr. Kevin Bryce Blumenthal, MD Urology Medicare: Medicare Enrolled Practice Location: 10710 Charter Dr, Suite 130, Columbia, MD 21044 Phone: 410-772-7000 Fax: 410-772-7072 | |
Katherine Smentkowski, Urology Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr Ste 130, Columbia, MD 21044 Phone: 800-953-3111 | |
Dr. Marc Brent Applestein, M.D. Urology Medicare: Medicare Enrolled Practice Location: 10710 Charter Dr, Suite 130, Columbia, MD 21044 Phone: 410-772-7000 Fax: 410-772-7072 |